Abstract
Purpose
The purpose of this work was to evaluate the association between coffee consumption and 10-year cardiovascular disease (CVD) incidence in the ATTICA study, and whether this is modified by the presence or absence of metabolic syndrome (MetS) at baseline.
Methods
During 2001–2002, 3042 healthy adults (1514 men and 1528 women) living in the greater area of Athens were voluntarily recruited to the ATTICA study. In 2011–2012, the 10-year follow-up was performed in 2583 participants (15% of the participants were lost to follow-up). Coffee consumption was assessed by a validated food-frequency questionnaire at baseline (abstention, low, moderate, heavy). Incidence of fatal or non-fatal CVD event was recorded using WHO-ICD-10 criteria and MetS was defined by the National Cholesterol Education Program Adult Treatment panel III (revised) criteria.
Results
Overall, after controlling for potential CVD risk factors, the multivariate analysis revealed a J-shaped association between daily coffee drinking and the risk for a first CVD event in a 10-year period. Particularly, the odds ratio for low (<150 ml/day), moderate (150–250 ml/day) and heavy coffee consumption (>250 ml/day), compared to abstention, were 0.44 (95% CI 0.29–0.68), 0.49 (95% CI 0.27–0.92) and 2.48 (95% CI 1.56–1.93), respectively. This inverse association was also verified among participants without MetS at baseline, but not among participants with the MetS.
Conclusions
These data support the protective effect of drinking moderate quantities of coffee (equivalent to approximately 1–2 cups daily) against CVD incidents. This protective effect was only significant for participants without MetS at baseline.
Similar content being viewed by others
References
O’Keefe JH, Bhatti SK, Patil HR, DiNicolantonio JJ, Lucan SC, Lavie CJ (2013) Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality. J Am Coll Cardiol 17(62):1043–1051. doi:10.1016/j.jacc.2013.06.035
Crippa A, Discacciati A, Larsson SC, Wolk A, Orsini N (2014) Coffee consumption and mortality from all causes, cardiovascular disease, and cancer: a dose–response meta-analysis. Am J Epidemiol 180:763–775. doi:10.1093/aje/kwu194
Lopez-Garcia E, van Dam RM, Qi L, Hu FB (2006) Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am J Clin Nutr 84:888–893
Liu J, Sui X, Lavie CJ, Hebert JR, Earnest CP, Zhang J, Blair SN (2013) Association of coffee consumption with all-cause and cardiovascular disease mortality. Mayo Clin Proc 88:1066–1074. doi:10.1016/j.mayocp.2013.06.020
Floegel A, Pischon T, Bergmann MM, Teucher B, Kaaks R, Boeing H (2012) Coffee consumption and risk of chronic disease in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Germany study. Am J Clin Nutr 95:901–908. doi:10.3945/ajcn.111.023648
Ding M, Bhupathiraju SN, Satija A, van Dam RM, Hu FB (2014) Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose–response meta-analysis of prospective cohort studies. Circulation 129:643–659. doi:10.1161/CIRCULATIONAHA.113.005925
Zampelas A, Panagiotakos DB, Pitsavos C, Chrysohoou C, Stefanadis C (2004) Associations between coffee consumption and inflammatory markers in healthy persons: the ATTICA study. Am J Clin Nutr 80:862–867
Yamashita K, Yatsuya H, Muramatsu T, Toyoshima H, Murohara T, Tamakoshi K (2012) Association of coffee consumption with serum adiponectin, leptin, inflammation and metabolic markers in Japanese workers: a cross-sectional study. Nutr Diabetes 2:e33. doi:10.1038/nutd.2012.6
Andersen LF, Jacobs DR Jr, Carlsen MH, Blomhoff R (2006) Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women’s Health Study. Am J Clin Nutr 83:1039–1046
Vlachopoulos C, Panagiotakos D, Ioakeimidis N, Dima I, Stefanadis C (2005) Chronic coffee consumption has a detrimental effect on aortic stiffness and wave reflections. Am J Clin Nutr 81:1307–1312
Mesas AE, Leon-Muñoz LM, Rodriguez-Artalejo F, Lopez-Garcia E (2011) The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis. Am J Clin Nutr 94:1113–1126. doi:10.3945/ajcn.111.016667
Pitsavos C, Panagiotakos DB, Chrysohoou C, Stefanadis C (2003) Epidemiology of cardiovascular risk factors in Greece: aims, design and baseline characteristics of the ATTICA study. BMC Public Health 3:32
Katsouyanni K, Rimm EB, Gnardellis C, Trichopoulos D, Polychronopoulos E, Trichopoulou A (1997) Reproducibility and relative validity of an extensive semi-quantitative food frequency questionnaire using dietary records and biochemical markers among Greek schoolteachers. Int J Epidemiol 26:S118–S127
Panagiotakos DB, Pitsavos C, Stefanadis C (2006) Dietary patterns: a Mediterranean diet score and its relation to clinical and biological markers of cardiovascular disease risk. Nutr Metab Cardiovasc Dis 16:559–568
Papathanasiou G, Georgoudis G, Papandreou M, Spyropoulos P, Georgakopoulos D, Kalfakakou V, Evangelou A (2009) Reliability measures of the short International Physical Activity Questionnaire (IPAQ) in Greek young adults. Hell J Cardiol 50:283–294
American Diabetes Association (1997) Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183–1197
Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C (2004) Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109:433–438
Bunker ML, McWilliams M (1979) Caffeine content of common beverages. J Am Diet Assoc 74:28–32
Panagiotakos DB, Georgousopoulou EN, Pitsavos C, Chrysohoou C, Metaxa V, Georgiopoulos GA, Kalogeropoulou K, Tousoulis D, Stefanadis C, ATTICA Study group (2015) Ten-year (2002–2012) cardiovascular disease incidence and all-cause mortality, in urban Greek population: the ATTICA study. Int J Cardiol 180:178–184. doi:10.1016/j.ijcard.2014.11.206
Zampelas A, Panagiotakos DB, Pitsavos C, Chrysohoou C, Stefanadis C (2004) Associations between coffee consumption and inflammatory markers in healthy persons: the ATTICA study. Am J Clin Nutr 80:862–867
Georgousopoulou EN, Kouli GM, Panagiotakos DB, Kalogeropoulou A, Zana A, Chrysohoou C, Tsigos C, Tousoulis D, Stefanadis C, Pitsavos C (2016) Anti-inflammatory diet and 10-year (2002–2012) cardiovascular disease incidence: the ATTICA study. Int J Cardiol 222:473–478. doi:10.1016/j.ijcard.2016.08.007
Czernichow S, Vergnaud AC, Galan P, Arnaud J, Favier A, Faure H, Huxley R, Hercberg S, Ahluwalia N (2009) Effects of long-term antioxidant supplementation and association of serum antioxidant concentrations with risk of metabolic syndrome in adults. Am J Clin Nutr 90:329–335. doi:10.3945/ajcn.2009.27635
Steinhubl SR (2008) Why have antioxidants failed in clinical trials? Am J Cardiol 101:14D–19D
Valtueña S, Pellegrini N, Franzini L, Bianchi MA, Ardigò D, Del Rio D, Piatti P, Scazzina F, Zavaroni I, Brighenti F (2008) Food selection based on total antioxidant capacity can modify antioxidant intake, systemic inflammation, and liver function without altering markers of oxidative stress. Am J Clin Nutr 87:1290–1297
Wyss-Coray T, Mucke L (2002) Inflammation in neurodegenerative disease—a double-edged sword. Neuron 35:419–432
Vakkila J, Lotze MT (2004) Inflammation and necrosis promote tumour growth. Nat Rev Immunol 4:641–648
Quinn MT, Gauss KA (2004) Structure and regulation of the neutrophil respiratory burst oxidase: comparison with nonphagocyte oxidases. J Leukoc Biol 76:760–781
Masella R, Di Benedetto R, Varì R, Filesi C, Giovannini C (2005) Novel mechanisms of natural antioxidant compounds in biological systems: involvement of glutathione and glutathione-related enzymes. J Nutr Biochem 16:577–586
Lockyer S, Rowland I, Spencer JP, Yaqoob P, Stonehouse W (2016) Impact of phenolic-rich olive leaf extract on blood pressure, plasma lipids and inflammatory markers: a randomised controlled trial. Eur J Nutr. doi:10.1007/s00394-016-1188-y
Agudelo-Ochoa GM, Pulgarín-Zapata IC, Velásquez-Rodriguez CM, Duque-Ramírez M, Naranjo-Cano M, Quintero-Ortiz MM, Lara-Guzmán OJ, Muñoz-Durango K (2016) Coffee consumption increases the antioxidant capacity of plasma and has no effect on the lipid profile or vascular function in healthy adults in a randomized controlled trial. J Nutr 146:524–531
Chang WC, Chen CH, Lee MF, Chang T, Yu YM (2010) Chlorogenic acid attenuates adhesion molecules upregulation in IL-1beta-treated endothelial cells. Eur J Nutr 49:267–275. doi:10.1007/s00394-009-0083-1
Panagiotakos DB, Pitsavos C, Chrysohoou C, Kokkinos P, Toutouzas P, Stefanadis C (2003) The J-shaped effect of coffee consumption on the risk of developing acute coronary syndromes: the CARDIO2000 case–control study. J Nutr 133:3228–3232
Zulli A, Smith RM, Kubatka P, Novak J, Uehara Y, Loftus H, Qaradakhi T, Pohanka M, Kobyliak N, Zagatina A, Klimas J, Hayes A, La Rocca G, Soucek M, Kruzliak P (2016) Caffeine and cardiovascular diseases: critical review of current research. Eur J Nutr 55:1331–1343. doi:10.1007/s00394-016-1179-z
Bohlscheid-Thomas S, Hoting I, Boeing H, Wahrendorf J (1997) Reproducibility and relative validity of energy and macronutrient intake of a food frequency questionnaire developed for the German part of the EPIC project. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 26(Suppl 1):S71–S81
Acknowledgements
The authors would like to thank the ATTICA study group of investigators: Yannis Skoumas, Natasa Katinioti, Labros Papadimitriou, Constantina Masoura, Spiros Vellas, Yannis Lentzas, Manolis Kambaxis, Konstanitna Paliou, Vassiliki Metaxa, Agathi Ntzouvani, Dimitris Mpougatas, Nikolaos Skourlis, Christina Papanikolaou, Aikaterini Kalogeropoulou, Evangelia Pitaraki, Alexandros Laskaris, Mihail Hatzigeorgiou and Athanasios Grekas, Eleni Kokkou for either assistance in the initial physical examination and follow-up evaluation, Efi Tsetsekou for her assistance in psychological evaluation and follow-up evaluation, as well as laboratory team: Carmen Vassiliadou and George Dedousis (genetic analysis), Marina Toutouza-Giotsa, Constantina Tselika and Sia Poulopouloou (biochemical analysis) and Maria Toutouza for the database management.
Author information
Authors and Affiliations
Contributions
GMK had the concept of the paper, performed data analyses and interpreted the results. DP, CC, and EG contributed by providing the design of the study, critically reviewed the paper and approved the final version, AZ, CT, DT, CS, and CP critically reviewed the paper. All authors approved the final version.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Funding
D.B. Panagiotakos and E. Georgousopoulou received research grants from Coca-Cola SA. The ATTICA study has been funded by research grants from the Hellenic Cardiology Society and the Hellenic Atherosclerosis Society.
Additional information
All authors state that they take the responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.
Rights and permissions
About this article
Cite this article
Kouli, GM., Panagiotakos, D.B., Georgousopoulou, E.N. et al. J-shaped relationship between habitual coffee consumption and 10-year (2002–2012) cardiovascular disease incidence: the ATTICA study. Eur J Nutr 57, 1677–1685 (2018). https://doi.org/10.1007/s00394-017-1455-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00394-017-1455-6